While some product categories experience seasonal ebbs and flows, the knife and multi-tool industry has a knack for churning out noteworthy new items with stunning regularity. This year has been no ...

Johnson & Johnson has its first regulatory approval for FcRn blocker Imaavy, getting a green light in the US for the would-be blockbuster as a treatment for generalised myasthenia gravis (gMG).